Grignard Pure
Grignard Pure: Innovating antimicrobial air treatments, reducing airborne viruses for enhanced safety.
Founded
2020Grignard Pure: Innovating antimicrobial air treatments, reducing airborne viruses for enhanced safety.
Grignard Pure, founded with a mission to enhance public health safety, focuses on developing innovative antimicrobial air treatment technologies. Their core product is designed to kill 98% of the SARS-CoV-2 virus in the air, significantly reducing airborne virus particles. This technology serves as a crucial component in comprehensive safety protocols that include personal hygiene and protective measures. Grignard Pure aims to provide effective solutions for environments where air quality is paramount, such as healthcare facilities, public transportation, and indoor public spaces.
Notable figures associated with Grignard Pure include experts in chemistry and public health who contribute to the company's innovative approach. The company has garnered attention for its significant impact during the COVID-19 pandemic, providing a scientifically-backed method to mitigate airborne virus transmission. Their achievements include regulatory approvals and partnerships with key institutions to implement their technology in high-risk areas. Grignard Pure's contributions have been pivotal in advancing air treatment solutions, reinforcing their role in public health safety.
Companies similar to Grignard Pure include Micron Pure, MaskZero, Hygienica and Airionex.
Grignard Pure was founded in 2020.
Grignard Pure's headquarters is located in Rahway, NJ, US.
Grignard Pure's most recent funding round was for $1.4M (USD) in July 2022.
As of Jul 20, 2022, Grignard Pure has disclosed funding of $1.4M (USD). Undisclosed round amounts are excluded.
Grignard Pure has 14 employees as of Feb 4, 2024.
Airionex
airionex.com
